Travere Therapeutics, Inc. TVTX
Price alert —
Sign in to get a one-time email the moment TVTX crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · TVTX
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.1B | $-0.0B | $-0.0B | $-0.1B | -29.2% | -29.0% |
| 2025-12-31 | $0.1B | $0.0B | $-0.0B | $0.0B | 2.1% | -25.0% |
| 2025-09-30 | $0.2B | $0.0B | $0.0B | $-0.0B | 15.6% | 15.1% |
| 2025-06-30 | $0.1B | $-0.0B | $-0.0B | $-0.0B | -11.1% | -11.1% |
| 2025-03-31 | $0.1B | $-0.0B | $-0.0B | $-0.1B | -50.4% | -52.2% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare TVTX vs peers
Line TVTX up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with TVTX
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-04 | 0.05 | -0.06 | +187.0% | -0.2% |
| 2026-02-19 | 0.37 | 0.37 | -0.8% | +3.7% |
| 2025-10-30 | 0.59 | -0.08 | +794.1% | +18.6% |
| 2025-08-06 | 0.13 | 0.04 | +225.0% | -1.9% |
| 2025-05-01 | -0.19 | -0.39 | +51.8% | +1.9% |
| 2025-02-20 | -0.47 | -0.38 | -24.1% | -6.8% |
| 2024-10-31 | -0.46 | -0.54 | +14.3% | +0.4% |
| 2024-08-01 | -0.65 | -0.72 | +9.2% | -2.6% |
| 2024-05-06 | -1.51 | -0.79 | -90.6% | +3.0% |
| 2024-02-15 | -0.94 | -0.92 | -2.0% | -6.2% |
| 2023-11-07 | 2.27 | 0.04 | +5413.7% | -11.8% |
| 2023-08-03 | -0.77 | -0.93 | +17.0% | -4.7% |
| 2023-05-04 | -0.82 | -1.03 | +20.1% | +5.2% |
| 2023-02-23 | -0.76 | -0.84 | +9.2% | +1.9% |
| 2022-10-27 | -0.76 | -0.70 | -7.9% | +2.0% |
| 2022-08-04 | -0.65 | -0.70 | +6.9% | +7.9% |
| 2022-05-05 | -0.82 | -0.73 | -12.5% | -9.6% |
| 2022-02-24 | -0.61 | -0.50 | -22.1% | -1.1% |
| 2021-10-28 | -0.13 | -0.48 | +73.1% | +8.3% |
| 2021-07-29 | -0.39 | -0.50 | +22.0% | -0.7% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| TVTX ★ | $5B | — | 11.7 | 9.8 | 331.7 | 53.1 | 55.9% | 55.6% | — | -0.97% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 60.03%
| Holder | Shares | % out |
|---|---|---|
| Janus Henderson Group PLC | 11,419,586 | 12.28% |
| FMR, LLC | 10,967,967 | 11.79% |
| Blackrock Inc. | 7,792,033 | 8.38% |
| State Street Corporation | 4,959,988 | 5.33% |
| Armistice Capital, LLC | 4,897,417 | 5.27% |
| Perceptive Advisors Llc | 4,142,551 | 4.45% |
| Vanguard Capital Management LLC | 4,045,812 | 4.35% |
| Nomura Asset Management Internationa | 3,270,513 | 3.52% |
| Geode Capital Management, LLC | 2,369,559 | 2.55% |
| Renaissance Technologies, LLC | 1,966,779 | 2.11% |
Insider activity · 90d
8 buys / 2 sells · ratio 4.0 · Finnhub
- Inrig Jula G 112,770
- Baynes Roy D. M 0
- Baynes Roy D. SELL 41,500 @ $50.00
- Baynes Roy D. M 46,000 @ $21.38
- Coughlin Timothy M 0
- Coughlin Timothy SELL 56,250 @ $50.07
- Coughlin Timothy M 66,250 @ $26.52
- Baynes Roy D. BUY 12,000
- Baynes Roy D. BUY 41,500
- Poole Sandra BUY 12,000
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 8-K | 2026-07-09 | 8-K | view · |
| 4 | 2026-06-22 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-16 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-16 | Insider transaction (Form 4) | view · |
| 8-K | 2026-06-16 | 8-K | view · |
| 8-K | 2026-06-02 | 8-K | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 8-K | 2026-05-21 | 8-K | view · |
| 4 | 2026-05-19 | Insider transaction (Form 4) | view · |
| 8-K | 2026-05-11 | 8-K | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 10-Q | 2026-05-04 | 10-Q | view · |
| 4 | 2026-05-04 | Insider transaction (Form 4) | view · |
| 8-K | 2026-05-04 | 8-K | view · |
| 4 | 2026-04-23 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-16 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-16 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-16 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-15 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-15 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-15 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-15 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-15 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-15 | Insider transaction (Form 4) | view · |
| 8-K | 2026-04-14 | 8-K | view · |
| 4 | 2026-04-07 | Insider transaction (Form 4) | view · |
| DEF 14A | 2026-04-06 | DEF 14A | view · |
| 4 | 2026-04-02 | Insider transaction (Form 4) | view · |
| 4 | 2026-04-02 | Insider transaction (Form 4) | view · |
| 4 | 2026-03-18 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-24 | Insider transaction (Form 4) | view · |
| 10-K | 2026-02-19 | 10-K | view · |
| 4 | 2026-02-19 | Insider transaction (Form 4) | view · |
| 8-K | 2026-02-19 | 8-K | view · |
| 4 | 2026-02-05 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-05 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-05 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-03 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-03 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-03 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-03 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-03 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-03 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-03 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-27 | Insider transaction (Form 4) | view · |
About TVTX
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. Its clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase, a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a collaboration agreement with PharmaKrysto Limited for the pre-clinical activities associated with the cystinuria program. Travere Therapeutics, Inc. was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics…
Options picks · TVTX
ITM + OTM ideas from the latest scanLoading…
Congress trades · TVTX
STOCK Act disclosuresLoading…
SEC filings & insiders · TVTX
EDGAR · liveLoading…
Holders · TVTX
Institutions & insider activityLoading…